MOTTOLA FRANK (Sr VP, Quality, GMP Oper. & IT) sold 47.5% of their position (14K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $623.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2025ACC: 0001804567-25-000004
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
-14K
Net shares
Net seller
$623.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
14K acquired · 28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14K
Price / share
$12.98
Trade value
$181.72K
% of position
90.3%
8/25/2025
15.50K→29.50K
Common Stock
Direct
Shares
−14K
Price / share
$44.51
Trade value
$623.14K
% of position
47.5%
8/25/2025
29.50K→15.50K
Total
Net shares
+0.00
Net value
-$441.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2025 | M · Option Exercise | +14K | $12.98 | $181.72K | 90.3% | 15.50K | 29.50K |
| Common Stock Direct | 8/25/2025 | S · Sale | −14K | $44.51 | $623.14K | 47.5% | 29.50K | 15.50K |
| Total | +0.00 | -$441.42K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14K shares
Shares
−14K
Strike price
12.98
Held after
0.00
Exercisable
—
8/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock14K shares | 8/25/2025 | M · Option Exercise | −14K | 12.98 | — | 0.00 |